Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report

September 22, 2009

NEW YORK, Sept. 22 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue.

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

http://www.reportlinker.com/p0120962/Vaccines-2009-World-Market-Analysis-Key-Players-and-Critical-Trends-in-a-Fast-Changing-Industry.html

The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions.

This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Changing Industry), examines the market for vaccines used in humans to previous various types of disease. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2008 period and forecasts are provided through 2013.

Since the last edition of this report:

  • Vaccine makers are now advertising directly to the public with growing DTC budgets. The report identifies the possible market impact of this new trend.
  • The economy has impacted vaccine sales with more people unable to make required out of pocket payments for vaccination.
  • New categories of vaccines, such as allergy vaccines, are becoming more prominent, and have been included in our forecasts.
  • Several major new products, including Wyeth’s Prevnar 13, are on the horizon. The market impact of new products is discussed.
  • Two major mergers – Pfizer/Wyeth and Merck/Schering-Plough, will impact the industry and this is considered in our market analysis.

Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2008. Since Kalorama Information last updated Kalorama Information’s The World Market for Vaccines last year, new products and better than expected profits have transformed the vaccine marketplace. Continued sales of influenza vaccines and cervical cancer vaccines have provided a foundation for growth in the adult market. The competitive dynamics have changed with mergers, and many new products are on the way.

Kalorama Information’s exhaustive research and analysis built from interviews with key decision makers in the market includes the following:

  • Review of Products in the Market
  • Current World Market Size for Pediatric and Adult Vaccines
  • Segmented Revenues and Forecasts to 2013 by Category
  • Over 45 Charts and Tables To Make Information Accessible
  • Discussion of The Current Economy and Vaccines, Immunization Refusal, Swine/Avian Flu and Other Pandemics, Delivery Sys and other Trends in the Vaccine Market
  • Important Vaccines and Immunization Schedules and Statistics
  • Profiles of 15 Key Vaccine Companies
  • Thorough Review of the Vaccine Pipeline and Possible Impact of New Products

Who are the main players in the vaccine market? What opportunities are available for pharmaceutical companies or investors from this market? What are the potential challenges vaccine competitors must deal with? What will be the impact of the first successful cancer product? What is the significance of at least one major acquisition to affect this industry? These questions and more are tackled in this report.

Current revenues and revenue forecasts to 2013 are included for the following pediatric vaccine categories:

  • DTaP & DTP Vaccines
  • Hep Vaccines
  • HiB Vaccines
  • MMR Vaccines
  • Combination Vaccines
  • Pneumococcal Vaccines
  • Polio Vaccines
  • Varicella Vaccines
  • Other Pediatric Vaccines

As well as Revenues and Forecasts to 2012 for the following adult vaccine categories:

  • Influenza Vaccines
  • Hepatitis Vaccines
  • Pneumococcal Vaccines
  • Travel, DT and other Adult Vaccines
  • Cervical Cancer

This is a rapidly changing marketplace and knowledge of the R&D pipeline is essential to truly understand what is happening in vaccines. Vaccines in development are discussed in this report, including vaccines for the following conditions:

  • Enterotoxigenic Escherichia coli
  • Parainfluenza Virus Type 3
  • Pneumococcal Vaccines
  • Respiratory Syncytial Virus
  • Cancers
  • Cholera
  • HIV/AIDS
  • Helicobacter Pylori
  • Malaria
  • Rabies
  • Tuberculosis
  • West Nile Virus

This Kalorama Information report was created with a primary research effort. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.

CHAPTER ONE: EXECUTIVE SUMMARY

THE GLOBAL VACCINES INDUSTRY

Scope And Methodology

Overview

Pediatric Preventative Vaccines

The Market

Adult Preventative Vaccines

The Market

Total Market

Issues and Trends

CHAPTER TWO: INTRODUCTION TO VACCINES

A Brief History: The Development of Vaccines

The Immune Response

Mechanism of Action

Types of Vaccines

Attenuated (Weakened) Live Viruses

Killed (Inactivated) Viruses

Toxoid Vaccines

Genetically Engineered/Modified Vaccines

Subunit Vaccines

Conjugate Vaccines

DNA Vaccination

Vaccine Approval Process

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

Introduction

Childhood Immunization in the United States

Childhood Immunization Rates

Challenges to the Vaccine Delivery System

Recommended Childhood Immunization Schedule

State Immunization Recommendations

Pediatric Vaccine Products

BCG

Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio

Diphtheria

Pertussis

Tetanus

Hepatitis B

Poliomyelitis

Enterotoxigenic Escherichia coli

Haemophilus Influenzae Type B

Hepatitis A

Measles, Mumps and Rubella

Measles

Mumps

Rubella

Meningococcal Disease

Parainfluenza Virus Type 3

Pneumococcal Conjugate

Respiratory Syncytial Virus

Rotavirus

Varicella

Pediatric Vaccines in Development

Global Initiatives for Vaccine Research

Cost of Vaccines in the United States

The World Market for Pediatric Preventive Vaccines

Total Market Size and Forecast

Hepatitis Vaccine Market

Market Analysis

Leading Products and Competitors

Haemophilus Influenzae Type B Vaccine Market

Market Analysis

Leading Products and Competitors

Measles, Mumps and Rubella Vaccines

Market Analysis

Combination Vaccines Market

Market Analysis

Leading Products and Competitors

Pneumococcal Vaccine

Leading Products and Competitors

Poliovirus Vaccine

Market Analysis

Leading Products and Competitors

Varicella Vaccines

Market Analysis

Leading Products and Competitors

Other Vaccines Market

Market Analysis

Leading Products and Competitors

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

Introduction

Adult Vaccine-Preventable Diseases: Facts and Figures

Global Virological Surveillance Program

Recommendations for Adult Immunizations

WHO International Health Regulations

Adult Vaccine Products

Allergy

BCG

Cancer

Cervical Cancer

Cholera

Diphtheria-Tetanus

Helicobacter Pylori

Hepatitis

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D

Hepatitis E

Herpesvirus

HIV/AIDS

Influenza

Japanese Encephalitis

Leishmaniasis

Malaria

Pneumococcal Disease

Rabies

Shingles

Tuberculosis

Typhoid Fever

West Nile Virus

Yellow Fever

Adult Vaccines in Development

Global Initiatives for Vaccine Research

The World Market for Adult Preventive Vaccines

Total Market Size and Forecast

Cervical Cancer Market

Market Analysis

Leading Products and Competitors

Hepatitis Market

Market Analysis

Leading Products and Competitors

Influenza Vaccine Market

Market Analysis

Leading Products and Competitors

Market Analysis

Leading Products and Competitors

Travel, DT, and Miscellaneous Vaccine Market

Market Analysis

Leading Products and Competitors

CHAPTER FIVE: VACCINES MARKET SUMMARY

Trends Driving the Vaccines Market

Market Size and Forecast

Vaccine Market Competitors

Pediatric Vaccines

Major Manufacturer’s Market Share

Adult Vaccines

Major Manufacturer’s Market Share

CHAPTER SIX: ISSUES AND TRENDS

Vaccine Safety

Refusal to Immunize

Post-Licensure Surveillance

Vaccine Adverse Event Reporting System

The Vaccine Safety Datalink Project

Phase IV studies

The Vaccine Injury Compensation Program

World Health Organization

Other Initiatives

The Future of Vaccine Safety

Vaccine Shortages

Preventing Shortages in the Developed Countries

Financial incentives

Equitable pricing

Vaccine stockpiles

Preventing Shortages in Developing Nations

Vaccine bonds

Economic Effects

Industrialized Nations

Developing Nations

Preventing Pandemics

U.S. National Vaccine Plan

Vaccines and Bioterrorism

Overview

Project Bioshield Act of 2004

National Bio and Agro-Defense Facility

Vaccine Treatment and Evaluation Units

Anthrax

Smallpox

Plague

Botulism

Tularemia

Viral Hemorrhagic Fevers

DNA Vaccination

Innovations in Vaccine Delivery Systems

Edible Vaccines

Mucosal Delivery

Intranasal Delivery

Vaccine Patches

DTC Advertising

CHAPTER SEVEN: COMPANY PROFILES

Acambis plc

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

AlphaVax, Inc.

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Bavarian Nordic A/S

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Baxter Healthcare

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Celldex Therapeutics

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Crucell

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Emergent Biosolutions

History and Lines of Business

Strategic Acquisition and Alliance

Vaccine Products

Financial

GlaxoSmithKline

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Medimmune

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Merck & Co. Inc

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Nabi Biopharmaceuticals

History and Lines of Business

Strategic Alliance

Vaccine Products

Financial Information

Novartis

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

History and Lines of Business

Strategic alliances

Vaccine products

Financial Information

Pharmexa

History and Lines of Business

Strategic alliances

Vaccine Products

Financial Information

Sanofi Pasteur

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Wyeth

History and Lines of Business

Vaccine Products

Financial Information

APPENDIX: COMPANY DIRECTORY LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: World Market for Pediatric Vaccines 2004-2013

Figure 1-2: World Market for Adult Vaccines 2004-2013

CHAPTER TWO: INTRODUCTION TO VACCINES

Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs. 2008

Table 2-2: Vaccine-Preventable Diseases, April 2009

Table 2-3: VAERS Table of Reportable Events Following Vaccination

Table 2-3 (cont.): VAERS Table of Reportable Events Following Vaccination

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

Table 3-1: Global Immunization Rates by Vaccine Type 2007

Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2000-2007

Table 3-3: U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2009

Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2009

Table 3-5: Selected Pediatric Vaccines in Development, April 2009

Table 3-6: World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others) 2004-2013 Revenues (in millions)

Figure 3-1: Market Share of Pediatric Vaccines by Type 2008 (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)

Figure 3-2: Market Share of Pediatric Vaccines, by Type 2013 (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)

Table 3-7: World Pediatric Hepatitis Vaccine Market 2004-2013

Table 3-8: World Hib Vaccine Market, 2004-2013

Table 3-9: World MMR Vaccines Market 2004-2013

Table 3-10: World Combination Vaccines Market 2004-2013

Table 3-11: World Pediatric Pneumococcal Vaccine Market 2004-2013

Table 3-12: World Poliovirus Vaccine Market 2004-2013

Table 3-13: World Varicella Vaccine Market 2004-2013

Table 3-14: Other Vaccines Market 2004-2013

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

Table 4-1: Universal Adult Immunization Schedule 2009

Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2008

Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2009

Table 4-4: WHO Pandemic Classification Schedule

Table 4-5: Selected Adult Preventive Vaccines in Development, 2009

Table 4-6: World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2004-2013 Revenues (in millions)

Figure 4-1: Market Share of Adult Vaccines, by Type, 2009

Figure 4-2: Market Share of Adult Vaccines, by Type, 2013

Table 4-7: World Cervical Cancer Vaccine Market 2004-2013

Table 4-8: World Hepatitis Vaccine Market 2004-2014

Table 4-9: World Influenza Vaccine Market 2004-2013

Table 4-10: CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs. 2010)

Table 4-11: 2007 Estimated Population by Region and Selected Age Group (in millions)

Table 4-12: World Pneumococcal Vaccine Market 2004-2013

Table 4-13: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2004-2013

CHAPTER FIVE: VACCINES MARKET SUMMARY

Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals 2004-2013

Figure 5-2: World Market for Vaccines by Type 2004-2013

Table 5-1: The World Vaccines Market by Vaccine Type 2004-2013 Revenues (in millions)

Figure 5-3: World Market for Vaccines Share by Type, 2004, 2008 and 2013

Table 5-2: Major Manufacturers’ Shares of the World Vaccine Market, 2008

Figure 5-3: 2008 World Vaccines Market Share, by Leading Competitors

Table 5-3: Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2008

Figure 5-5: Market Share of Pediatric Vaccines Market, 2008

Table 5-4: Major Manufacturer’s Shares of the World Adult Vaccine Market 2008

Figure 5-6: Market Share of Adult Vaccines Market 2008

CHAPTER SIX: ISSUES AND TRENDS

Table 7-1: Selected Companies/Laboratories Developing Biodefense Vaccines

To order this report:

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

http://www.reportlinker.com/p0120962/Vaccines-2009-World-Market-Analysis-Key-Players-and-Critical-Trends-in-a-Fast-Changing-Industry.html

More market research reports here!

    CONTACT:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


Source: newswire